Comparative study of three different dosing regimens of cefotaxime for treatment of gram-negative bacteremia
- 28 February 1989
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (1) , 107-111
- https://doi.org/10.1016/0732-8893(89)90054-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Role of pharmacokinetics in the outcome of infectionsAntimicrobial Agents and Chemotherapy, 1988
- Optimal cefotaxime dosing for gram-negative bacteremia: Effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusionsDiagnostic Microbiology and Infectious Disease, 1988
- Physiologic abnormalities and outcome from acute disease. Evidence for a predictable relationshipArchives of internal medicine (1960), 1986
- Cefotaxime Compared with Nafcillin Plus Tobramycin for Serious Bacterial InfectionsAnnals of Internal Medicine, 1984
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Clinical Pharmacokinetics of Cefotaxime in Patients with Normal and Reduced Renal FunctionClinical Infectious Diseases, 1982
- Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of SynergyClinical Infectious Diseases, 1982
- Clinical efficacy of cefotaxime in serious infectionsAntimicrobial Agents and Chemotherapy, 1982
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978
- Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic DiluentThe Journal of Infectious Diseases, 1977